| abstract |
Disclosed herein are methods of treating neurodegenerative diseases comprising administering to the subject a compound having the structure: n n n n n n n n n n wherein α and R 1 -R 8 are described herein, or a compound having the structure: n n n n n n n n n n wherein Y, Z, and R 21 , R 24 , R 25 , and R 31 -R 33 are described herein. |